arrow
Back
G

Gregory M. Coté

massachusetts general hospital and harvard medical school

43H-index
321Paper Count
6.3KCitation Count
Published Papers 84
Publication Date
A POOLED ANALYSIS OF PHASE 2 CLINICAL TRIALS IN ADVANCED CHORDOMA
err2026-06-10
err0
PREAI
errGregory M. Cote; Corrine F. Elliott; Astrid Lipplaa; Hans Gelderblom; Jean-Yves Blay; Axel Le Cesne; Florence Duffaud; Santosh Kesari; Suzanne George; Neeta Somaiah; Anthony P. Conley; Maria-Veronica Teleanu; Stefan Fröhling; Richard F. Schlenk; Emmanuelle Bompas; Scott M. Schuetze; Rashmi Chugh; Edwin Choy; Teja Chemudupati; Shannon Lozinsky
errShare
errSave
Clinicopathologic evaluation of dedifferentiated liposarcoma lacking MDM2 amplification
err2026-05-07
err0
PREAI
errCharlotte I Wang; Soma Jobbagy; Anne B Giersch; Jonathan B Greer; Kevin X Liu; Gregory M Cote; Yin P Hung; G Petur Nielsen; Ivan Chebib
errShare
errSave
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
err2026-03-25
err0
errOAAI
errMrinal Gounder; Patrick Schöffski; Robin L. Jones; Silvia Stacchiotti; George D. Demetri; Gregory M. Cote; Mark Agulnik; Rashmi Chugh; Thierry Jahan; Abha A. Gupta; Tom Wei-Wu Chen; Ravin Ratan; Palma Dileo; Alexander Drilon; Gabriel G. Malouf; Attila Szanto; Neal Gupta; Nizar M. Tannir
errShare
errSave
Combination of Lurbinectedin plus Irinotecan: Preclinical and Early Clinical Results in Relapsed Small Cell Lung Cancer Patients
err2026-03-04
err0
PREAI
errSantiago Ponce; Miguel Ruiz-Torres; Alejandro Falcón; Gregory M. Cote; Reyes Bernabé; Jessica J. Lin; Juan Manuel Coya; Marta Jiménez-Muñoz; Pablo Fernández-Puyuelo; Amparo Sánchez; Jon Zugazagoitia; Alvaro Ucero; Javier Baena; Helena Bote de Cabo; Mercedes Herrera; Javier Torres-Jiménez; Maria Zurera; Carmen Kahatt; Jose Antonio Lopez-Vilariño; Sara Martinez
errShare
errSave
Prospective, Randomized Dose Escalation Trial with Proton-Based Radiation for Skull Base and Cervical Spine Chondrosarcomas: 30-year outcomes from PROG 85-26
err2025-12-18
err0
PREAI
errMyrsini Ioakeim-Ioannidou; Beow Y Yeap; Zainab O Soetan; Daniel W Kim; Daniel Packard; Rana Hegazy; Engy S Todary; Athena Tejada; Judith Adams; Hanne Kooy; Stephen Zieminski; Nicolas Depauw; G Petur Nielsen; Yin P Hung; Andrew Rosenberg; Daniel G Tobert; Ganesh Shankar; William T Curry; Gregory M Cote; Hillary R Kelly; Mary Elizabeth Cunnane; Yuh-Shin Chang; Paul Gardner; Fantine Giap; Yen-Lin Chen; Thomas F Delaney; Eugen Hug; Kevin X Liu; Helen A Shih; Shannon M Macdonald
errShare
errSave
Long-term Outcomes Following Proton-based Radiation Therapy for Pediatric Chordomas and Chondrosarcomas of the Mobile Spine and the Sacrum
err2025-04-07
err0
PREAI
errMyrsini Ioakeim-Ioannidou; Andrzej Niemierko; Timur Mukhammadov; Drosoula Giantsoudi; David J. Konieczkowski; Daniel W. Kim; Athena Tejada; Maria Tolia; G. Petur Nielsen; Yin P. Hung; Gregory Cote; Daniel G. Tobert; John Shin; Thomas F. DeLaney; Yen-Lin Chen; Fantine Giap; Shannon M. MacDonald
errShare
errSave
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
err2025-02-11
err0
errOAAI
errCote, Gregory M.; Chawla, Sant P.; Demetri, George; Kasper, Bernd; Jones, Robin L.; Broto, Javier Martin; Wooley, Joseph; Weiss, Mia C.; Tafuto, Salvatore; Badalamenti, Giuseppe; Carrasco, Irene; Peinado, Paloma; Blay, Jean-Yves; Boggio, Gaston; Fernandez, Cristian; Nieto, Antonio; Kahatt, Carmen; Alfaro, Vicente; Le Cesne, Axel
errShare
errSave
Proton-Based Radiation Therapy for Skull Base Chondrosarcomas in Children and Adolescents: 40-Year Experience From the Massachusetts General Hospital
err2025-02-01
err0
PREAI
errIoakeim-Ioannidou, Myrsini; Goldberg, Saveli; Urell, Tobias; Tejada, Athena; Nielsen, G. Petur; Hung, Yin P.; Adams, Judith; Fullerton, Barbara; Caruso, Paul; Patino, Manuel; Buch, Karen; Rincon, Sandra; Sakai, Osamu; Tolia, Maria; Ebb, David; Cote, Gregory; Curry, William; Giantsoudi, Drosoula; Macdonald, Shannon M.
errShare
errSave
Genomic and transcriptomic analysis of chondrosarcomas to explore new potential treatment options
err2024-09-01
err0
PREAI
errZirov, K.; Voropaeva, M.; Aukhadieva, A.; Makarova, A.; Shevkoplias, A. E.; Novokreshchenova, A.; Dubrovskaya, A.; Lebedev, D.; Yong, S. T.; Brown, J. H.; Chawla, S. P.; Cote, G. M.; Livingston, J. A.; Subbiah, V.; Araujo, D.; Bagaev, A.; Bednyagin, L.; Conley, A. P.
errShare
errSave
Phase II data of lurbinectedin (LUR) and irinotecan (IRI) in relapsed small cell lung cancer (SCLC) patients (pts) with chemotherapy-free interval (CTFI)>30 days (d)
err2024-09-01
err0
PREAI
errZugazagoitia, J.; Falcon Gonzalez, A.; Navarro Mendivil, A. F.; Sanchez Gastaldo, A.; Simoes da Rocha, P. F.; Cote, G. M.; Bockorny, B.; Molina Cerrillo, J.; Artal, A.; Baena Espinar, J.; Gil Torralvo, A.; Ponce Aix, S.; Bote De Cabo, H.; Martinez Perez, J.; Martinez, S.; Lopez-Vilarino, J. A.; Kahatt, C.; Gomez, J.; Paz-Ares, L. G.
errShare
errSave
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma
errCANCER
IF5.1
err2024-07-10
err1
PREAI
errCote, Gregory M.; Conley, Anthony P.; Attia, Steven; Van Tine, Brian A.; Seetharam, Mahesh; Chen, Yen-Lin; Gafoor, Zarina; Heery, Christopher; Pico-Navarro, Cesar; Adams, Tatiana
errShare
errSave
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
err2024-05-06
err2
errOAAI
errFontana, Elisa; Rosen, Ezra; Lee, Elizabeth K.; Hojgaard, Martin; Mettu, Niharika B.; Lheureux, Stephanie; Carneiro, Benedito A.; Cote, Gregory M.; Carter, Louise; Plummer, Ruth; Mahalingam, Devalingam; Fretland, Adrian J.; Schonhoft, Joseph D.; Silverman, Ian M.; Wainszelbaum, Marisa; Xu, Yi; Ulanet, Danielle; Koehler, Maria; Yap, Timothy A.
errShare
errSave
A dose escalation and cohort expansion study of the CDK9 inhibitor KB-0742 in triple negative breast cancer and transcriptionally addicted relapsed or refractory solid tumors
err2024-05-02
err0
PREAI
errMita, Monica; Mita, Alain; Villalona-Calero, Miguel; Federman, Noah; Rasco, Drew; Spigel, David; Luo, Jia; Cote, Gregory; Cutler, Richard; Kumar, Pavan; MacKenzie, Crystal; Lin, Charles; DiMartino, Jorge; Olek, Elizabeth; Van Tine, Brian
errShare
errSave
A dose escalation and cohort expansion study of the CDK9 inhibitor KB0742 in relapsed, refractory and transcriptionally addicted solid tumors
err2024-04-05
err0
PREAI
errCalero, Miguel Villalona; Agulnik, Mark; Mita, Monica; Mita, Alain; Federman, Noah; Rasco, Drew; Spigel, David; Luo, Jia; Hanna, Glenn; Cote, Gregory; Salkeni, Mohamad A.; Chugh, Rashmi; Ammakkanavar, Natraj R.; Shah, Satish A.; Rao, Amol; Sankhala, Kamalesh Kumar; Cutler, Richard E.; Hood, Tressa; Carvajal, Luis; MacKenzie, Crystal; Lin, Charles; DiMartino, Jorge; Olek, Elizabeth A.; Van Tine, Brian
errShare
errSave
Customized liquid biopsy assay for monitoring EWSR1 fusions in sarcomas
err2024-03-22
err0
PREAI
errLi, Annie; Thierauf, Julia C.; Gonda, Bianca; Purohit, Rashi; Kaluziak, Stefan T.; Codd, Elizabeth; Dybel, Stacey N.; Choy, Edwin; Cote, Gregory M.; Lennerz, Jochen K.; Iafrate, A. John
errShare
errSave
A dose escalation and cohort expansion study of the CDK9 inhibitor KB0742 in relapsed, refractory ovarian cancer and transcriptionally addicted relapsed or refractory solid tumors
err2024-03-04
err0
PREAI
errVillalona-Calero, Miguel; Mita, Monica; Mita, Alain; Federman, Noah; Rasco, Drew; Spigel, David; Luo, Jia; Cote, Gregory M.; Cutler, Richard E.; Kumar, Pavan; MacKenzie, Crystal J.; Lin, Charles; DiMartino, Jorge F.; Olek, Elizabeth A.; Van Tine, Brian
errShare
errSave
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours
err2024-01-29
err10
errOAAI
errBurris, Howard A.; Berlin, Jordan; Arkenau, Tobias; Cote, Gregory M.; Lolkema, Martijn P.; Ferrer-Playan, Jordi; Kalapur, Anup; Bolleddula, Jayaprakasam; Locatelli, Giuseppe; Goddemeier, Thomas; Gounaris, Ioannis; de Bono, Johann
errShare
errSave
Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11 (vol 7, 43941,2017)
err2024-01-22
err0
errOAAI
errLiao, Yunfei; Sassi, Slim; Halvorsen, Stefan; Feng, Yong; Shen, Jacson; Gao, Yan; Cote, Gregory; Choy, Edwin; Harmon, David; Mankin, Henry; Hornicek, Francis; Duan, Zhenfeng
errShare
errSave
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
err2024-01-18
err6
errOAAI
errHaddox, Candace L.; Nathenson, Michael J.; Mazzola, Emanuele; Lin, Jia-Ren; Baginska, Joanna; Nau, Allison; Weirather, Jason L.; Choy, Edwin; Marino-Enriquez, Adrian; Morgan, Jeffrey A.; Cote, Gregory M.; Merriam, Priscilla; Wagner, Andrew J.; Sorger, Peter K.; Santagata, Sandro; George, Suzanne
errShare
errSave
Assessing replication stress as an actionable therapeutic opportunity in chordoma
err2024-01-09
err0
PREAI
errPunturi, Nindo; Leung, Wendy; Levy, Joan; Zou, Lee; Cote, Gregory M.; Freed, Dan M.
errShare
errSave